| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $381.21M | - | |
| Other | 278.6K | $45.41M | - | |
| Other | 232.5K | $37.89M | - | |
| COO | 119.9K | $19.54M | - | |
| ? | 96.6K | $15.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | Patel Sushil66 | Director | Sale+OE | 5,000 | $54.14 | $270,714.50 | -20.0% | -23.5% | +10.0% | |
| Oct 14, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,666 | $49.49 | $824,804.42 | -3.0% | -13.5% | -3.5% | |
| Oct 11, 2024 | Horn Margaret A48 | Chief Operating Officer | Sale+OE | 50,000 | $50.34 | $2,517,055.00 | -27.4% | -17.2% | -4.4% | |
| Oct 11, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 30,000 | $50.36 | $1,510,773.00 | -9.1% | -17.2% | -4.4% | |
| Oct 11, 2024 | Anders Jack47 | Chief Financial Officer | Sale+OE | 10,000 | $50.30 | $502,979.00 | -9.2% | -17.2% | -4.4% | |
| Oct 11, 2024 | Cislini Jeff | General Counsel | Sale+OE | 6,000 | $50.17 | $301,026.60 | -11.6% | -17.2% | -4.4% | |
| Oct 8, 2024 | Weber Barbara59 | Director | Sell | 5,200 | $48.02 | $249,716.48 | -28.5% | -11.9% | -3.9% | |
| Oct 1, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 10,000 | $44.93 | $449,322.06 | -1.6% | -4.4% | +1.5% | |
| Sep 16, 2024 | Anders Jack47 | Chief Financial Officer | Sell | 2,244 | $44.19 | $99,151.81 | -2.2% | +0.4% | +0.4% | |
| Sep 16, 2024 | Goldsmith Mark A52 | See Remarks | Sell | 11,715 | $44.19 | $517,630.79 | -3.8% | +0.4% | +0.4% |